These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30007111)

  • 1. Laboratory criteria for antiphospholipid syndrome: reply.
    Devreese KMJ; Ortel TL; Pengo V; de Laat B
    J Thromb Haemost; 2018 Oct; 16(10):2117-2119. PubMed ID: 30007111
    [No Abstract]   [Full Text] [Related]  

  • 2. Laboratory criteria for antiphospholipid syndrome: comment.
    Lackner KJ; Müller-Calleja N
    J Thromb Haemost; 2018 Oct; 16(10):2115-2116. PubMed ID: 30007114
    [No Abstract]   [Full Text] [Related]  

  • 3. In reply: 'Non-criteria' antiphospholipid antibodies and thrombosis.
    Serhal M; Gornik H; Evans N
    Cleve Clin J Med; 2018 Jun; 85(6):432. PubMed ID: 29883313
    [No Abstract]   [Full Text] [Related]  

  • 4. Laboratory Evaluation of Antiphospholipid Syndrome: An Update on Autoantibody Testing.
    Tebo AE
    Clin Lab Med; 2019 Dec; 39(4):553-565. PubMed ID: 31668269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiphospholipid antibodies and cancer].
    Scrobohaci ML
    Pathol Biol (Paris); 2008 Jun; 56(4):245-50. PubMed ID: 18456436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH.
    Devreese KMJ; Ortel TL; Pengo V; de Laat B;
    J Thromb Haemost; 2018 Apr; 16(4):809-813. PubMed ID: 29532986
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiphosphatidylethanolamine antibodies and the antiphospholipid syndrome.
    Sanmarco M; Boffa MC
    Lupus; 2009 Sep; 18(10):920-3. PubMed ID: 19671793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-criteria Antiphospholipid Antibodies: a narrative review.
    Funke A; Staub HL; Monticielo OA; Balbi GGM; Danowski A; Santiago MB; Andrade DCO; Rêgo J
    Rev Assoc Med Bras (1992); 2020 Nov; 66(11):1595-1601. PubMed ID: 33295416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibodies--we are not quite there yet.
    Urbanus RT; de Groot PG
    Blood Rev; 2011 Mar; 25(2):97-106. PubMed ID: 21242018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of the antiphospholipid syndrome revisited: time to challenge the dogma: reply.
    Lackner KJ; Müller-Calleja N
    J Thromb Haemost; 2016 Dec; 14(12):2563-2564. PubMed ID: 27696707
    [No Abstract]   [Full Text] [Related]  

  • 11. 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends.
    Bertolaccini ML; Amengual O; Andreoli L; Atsumi T; Chighizola CB; Forastiero R; de Groot P; Lakos G; Lambert M; Meroni P; Ortel TL; Petri M; Rahman A; Roubey R; Sciascia S; Snyder M; Tebo AE; Tincani A; Willis R
    Autoimmun Rev; 2014 Sep; 13(9):917-30. PubMed ID: 24824074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avidity of antiphospholipid antibodies - our current knowledge.
    Fialová L
    Epidemiol Mikrobiol Imunol; 2014 Sep; 63(3):221-5. PubMed ID: 25412487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 16th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.
    Cervera R; Rodríguez-Pintó I; Legault K; Erkan D
    Lupus; 2020 Oct; 29(12):1594-1600. PubMed ID: 32819183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The antiphospholipid syndrome and antiphospholipid antibodies].
    Malícková K; Fucíková T
    Cas Lek Cesk; 2001 Aug; 140(15):465-8. PubMed ID: 11569167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reply to: "Monitoring antivitamin K anticoagulants in antiphospholipid syndrome: A challenge in quality".
    Pastori D; Parrotto S; Vicario T; Saliola M; Mezzaroma I; Violi F; Pignatelli P
    Atherosclerosis; 2017 Jan; 256():148-149. PubMed ID: 27993386
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiphospholipid antibodies and the antiphospholipid syndrome II: limitations, standardization, and clinical utility of laboratory testing.
    Favaloro EJ; Wong RC
    Semin Thromb Hemost; 2008 Jun; 34(4):309-12. PubMed ID: 18814063
    [No Abstract]   [Full Text] [Related]  

  • 17. Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
    Vandevelde A; Chayoua W; de Laat B; Moore GW; Musiał J; Zuily S; Wahl D; Devreese KMJ
    J Thromb Haemost; 2022 Sep; 20(9):2136-2150. PubMed ID: 35713971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of patients with antiphospholipid antibodies: what to do in laboratory scenarios that do not fit the guidelines.
    Pires Da Rosa G; Rodríguez-Pintó I; Cervera R; Espinosa G
    Expert Rev Hematol; 2021 May; 14(5):457-466. PubMed ID: 33909986
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiphospholipid antibodies and the antiphospholipid antibody syndrome.
    Nahass GT
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):149-68; quiz 169-72. PubMed ID: 9039162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid syndrome and IgA anti-beta2-glycoprotein I antibodies: when Cinderella becomes a princess.
    Pérez D; Tincani A; Serrano M; Shoenfeld Y; Serrano A
    Lupus; 2018 Feb; 27(2):177-178. PubMed ID: 29067871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.